InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,214.08
(
0.51%
)
US TECH 100
17,658.00
(
0.32%
)
Dow Jones
39,387.76
(
0.85%
)
Brent Oil
84.29
(
0.40%
)
Bitcoin
62,921.44
(
-0.20%
)

Replies to post #90786 on Cytodyn Inc (CYDY)

Replies to #90786 on Cytodyn Inc (CYDY)

All-Bidness

07/04/20 6:12 PM

#90789 RE: Amatuer17 #90786

Hey I'll take converted Pesos, if the US wants to play games. 25 patients will go real quick.

All-Bidness

07/04/20 6:14 PM

#90790 RE: Amatuer17 #90786

Brazil needs it the most right now, they'll surpass us soon, which is sad.

Borel Fields

07/04/20 8:01 PM

#90829 RE: Amatuer17 #90786

Why more people in leron than lenzi phase III: 1) leron trial is 2:1 randomization - not as statistically efficient, (2) More patients ==> greater statistical resolution. If you want to make sure the trial detects a (underlying, long term) 50% reduction in deaths, you need fewer people than to be sure of detecting a 30% reduction. (3) Humanigen's endpoint is easier, so they are betting on big.